These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43. Circulating cytokines and gastric cancer risk. Epplein M; Xiang YB; Cai Q; Peek RM; Li H; Correa P; Gao J; Wu J; Michel A; Pawlita M; Zheng W; Shu XO Cancer Causes Control; 2013 Dec; 24(12):2245-50. PubMed ID: 24052422 [TBL] [Abstract][Full Text] [Related]
44. Helicobacter pylori seroprevalence in Spain: influence of adult and childhood sociodemographic factors. Lorenzo I; Fernández-de-Larrea N; Michel A; Romero B; Lope V; Bessa X; Moreno V; Martín V; Amiano P; Castilla J; Tardón A; Dierssen-Sotos T; Peiró R; Díaz-Santos M; Navarro C; Jiménez-Moleón JJ; Butt J; Barricarte A; Ruiz I; Molina-de-la-Torre AJ; Casabonne D; Pérez-Gómez B; Kogevinas M; Del Campo R; de Sanjosé S; Pollán M; Waterboer T; Aragonés N Eur J Cancer Prev; 2019 Jul; 28(4):294-303. PubMed ID: 30489354 [TBL] [Abstract][Full Text] [Related]
45. Association of Helicobacter pylori infection and environmental factors in non-cardia gastric cancer in Japan. Machida-Montani A; Sasazuki S; Inoue M; Natsukawa S; Shaura K; Koizumi Y; Kasuga Y; Hanaoka T; Tsugane S Gastric Cancer; 2004; 7(1):46-53. PubMed ID: 15052440 [TBL] [Abstract][Full Text] [Related]
46. Cancer development based on chronic active gastritis and resulting gastric atrophy as assessed by serum levels of pepsinogen and Helicobacter pylori antibody titer. Yoshida T; Kato J; Inoue I; Yoshimura N; Deguchi H; Mukoubayashi C; Oka M; Watanabe M; Enomoto S; Niwa T; Maekita T; Iguchi M; Tamai H; Utsunomiya H; Yamamichi N; Fujishiro M; Iwane M; Takeshita T; Ushijima T; Ichinose M Int J Cancer; 2014 Mar; 134(6):1445-57. PubMed ID: 24009139 [TBL] [Abstract][Full Text] [Related]
47. Is the association between Helicobacter pylori and gastric cancer confined to CagA-positive strains? Held M; Engstrand L; Hansson LE; Bergström R; Wadström T; Nyrén O Helicobacter; 2004 Jun; 9(3):271-7. PubMed ID: 15165264 [TBL] [Abstract][Full Text] [Related]
48. Serum antibody positivity for distinct Helicobacter pylori antigens in benign and malignant gastroduodenal disease. Schumann C; Triantafilou K; Rasche FM; Möricke A; Vogt K; Triantafilou M; Hahn P; Schneider EM; Lepper PM Int J Med Microbiol; 2006 Aug; 296(4-5):223-8. PubMed ID: 16600680 [TBL] [Abstract][Full Text] [Related]
49. Interaction between dietary factors and Helicobacter pylori infection in noncardia gastric cancer: a population-based case-control study in China. Wang XQ; Yan H; Terry PD; Wang JS; Cheng L; Wu WA; Hu SK J Am Coll Nutr; 2012 Oct; 31(5):375-84. PubMed ID: 23529995 [TBL] [Abstract][Full Text] [Related]
50. Antibody against Helicobacter pylori CagA and VacA and the risk for gastric cancer. Yamaoka Y; Kodama T; Kashima K; Graham DY J Clin Pathol; 1999 Mar; 52(3):215-8. PubMed ID: 10450182 [TBL] [Abstract][Full Text] [Related]
51. Multiplex H. pylori Serology and Risk of Gastric Cardia and Noncardia Adenocarcinomas. Shakeri R; Malekzadeh R; Nasrollahzadeh D; Pawlita M; Murphy G; Islami F; Sotoudeh M; Michel A; Etemadi A; Waterboer T; Poustchi H; Brennan P; Boffetta P; Dawsey SM; Kamangar F; Abnet CC Cancer Res; 2015 Nov; 75(22):4876-83. PubMed ID: 26383162 [TBL] [Abstract][Full Text] [Related]
52. Relation of serum ascorbic acid to Helicobacter pylori serology in US adults: the Third National Health and Nutrition Examination Survey. Simon JA; Hudes ES; Perez-Perez GI J Am Coll Nutr; 2003 Aug; 22(4):283-9. PubMed ID: 12897042 [TBL] [Abstract][Full Text] [Related]
53. Helicobacter pylori infection and gastric cancer risk: evaluation of 15 H. pylori proteins determined by novel multiplex serology. Gao L; Michel A; Weck MN; Arndt V; Pawlita M; Brenner H Cancer Res; 2009 Aug; 69(15):6164-70. PubMed ID: 19602590 [TBL] [Abstract][Full Text] [Related]
54. Risk of gastric cancer in Helicobacter pylori infection in a 15-year follow-up. Vohlonen I; Pukkala E; Malila N; Härkönen M; Hakama M; Koistinen V; Sipponen P Scand J Gastroenterol; 2016 Oct; 51(10):1159-64. PubMed ID: 27338132 [TBL] [Abstract][Full Text] [Related]
55. Helicobacter pylori infection and low serum pepsinogen I level as risk factors for gastric carcinoma. Kokkola A; Louhimo J; Puolakkainen P; Alfthan H; Haglund C; Rautelin H World J Gastroenterol; 2005 Feb; 11(7):1032-6. PubMed ID: 15742409 [TBL] [Abstract][Full Text] [Related]
56. Helicobacter pylori antibodies in relation to precancerous gastric lesions in a high-risk Chinese population. Zhang L; Blot WJ; You WC; Chang YS; Kneller RW; Jin ML; Li JY; Zhao L; Liu WD; Zhang JS; Ma JL; Samloff IM; Correa P; Blaser MJ; Xu GW; Fraumeni JF Cancer Epidemiol Biomarkers Prev; 1996 Aug; 5(8):627-30. PubMed ID: 8824365 [TBL] [Abstract][Full Text] [Related]
57. Smoking, Butt J; Varga MG; Wang T; Tsugane S; Shimazu T; Zheng W; Abnet CC; Yoo KY; Park SK; Kim J; Jee SH; Qiao YL; Shu XO; Waterboer T; Pawlita M; Epplein M Cancer Prev Res (Phila); 2019 Oct; 12(10):667-674. PubMed ID: 31350279 [TBL] [Abstract][Full Text] [Related]
58. Role of Helicobacter pylori CagA+ strains and risk of adenocarcinoma of the stomach and esophagus. Wu AH; Crabtree JE; Bernstein L; Hawtin P; Cockburn M; Tseng CC; Forman D Int J Cancer; 2003 Mar; 103(6):815-21. PubMed ID: 12516104 [TBL] [Abstract][Full Text] [Related]
59. Different etiological role of Helicobacter pylori (Hp) infection in carcinogenesis between differentiated and undifferentiated gastric cancers: a nested case-control study using IgG titer against Hp surface antigen. Tatemichi M; Sasazuki S; Inoue M; Tsugane S; Acta Oncol; 2008; 47(3):360-5. PubMed ID: 18347999 [TBL] [Abstract][Full Text] [Related]
60. Meat intake and risk of stomach and esophageal adenocarcinoma within the European Prospective Investigation Into Cancer and Nutrition (EPIC). González CA; Jakszyn P; Pera G; Agudo A; Bingham S; Palli D; Ferrari P; Boeing H; del Giudice G; Plebani M; Carneiro F; Nesi G; Berrino F; Sacerdote C; Tumino R; Panico S; Berglund G; Simán H; Nyrén O; Hallmans G; Martinez C; Dorronsoro M; Barricarte A; Navarro C; Quirós JR; Allen N; Key TJ; Day NE; Linseisen J; Nagel G; Bergmann MM; Overvad K; Jensen MK; Tjonneland A; Olsen A; Bueno-de-Mesquita HB; Ocke M; Peeters PH; Numans ME; Clavel-Chapelon F; Boutron-Ruault MC; Trichopoulou A; Psaltopoulou T; Roukos D; Lund E; Hemon B; Kaaks R; Norat T; Riboli E J Natl Cancer Inst; 2006 Mar; 98(5):345-54. PubMed ID: 16507831 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]